Immuneering (IMRX) Intangibles (2021 - 2026)
Immuneering's (IMRX) quarterly Intangibles came in at $313830.0 in Q1 2026, down 8.53% year-on-year from $343097.0 in Q1 2025, and down 2.28% quarter-over-quarter from $321147.0 in Q4 2025.
Immuneering (IMRX) Intangibles (2021 - 2026) Analysis & Trends
Immuneering's Intangibles history runs 6 years deep, the most recent figure standing at $313830.0 for Q1 2026.
- On a quarterly basis, Intangibles fell 8.53% year-over-year to $313830.0 in Q1 2026; TTM through Mar 2026 was $313830.0, a 8.53% decrease from a year earlier, with the FY2025 full-year figure at $321147.0, down 8.35% from the prior year.
- Intangibles retreated to $313830.0 in Q1 2026 per IMRX's latest filing, from $321147.0 in the prior quarter.
- Across five years, Intangibles topped out at $430897.0 in Q1 2022 and bottomed at $313830.0 in Q1 2026.
- The 5-year median for Intangibles is $372363.0 (2024), against an average of $372363.4.
- Across the five-year window, Intangibles retreated 6.79% in 2023 and slipped 8.53% in 2026, its largest moves.
- Year by year, Intangibles stood at $408947.0 in 2022, then slipped by 7.16% to $379680.0 in 2023, then declined by 7.71% to $350413.0 in 2024, then retreated by 8.35% to $321147.0 in 2025, then fell by 2.28% to $313830.0 in 2026.
- Per Business Quant, the three latest IMRX Intangibles figures stand at $313830.0 (Q1 2026), $321147.0 (Q4 2025), and $328463.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Immuneering | 283.85 Mn | 283.85 Mn | - | 313,830.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 313,830.00 |
| Dec 31, 2025 | 321,147.00 |
| Sep 30, 2025 | 328,463.00 |
| Jun 30, 2025 | 335,780.00 |
| Mar 31, 2025 | 343,097.00 |
| Dec 31, 2024 | 350,413.00 |
| Sep 30, 2024 | 357,730.00 |
| Jun 30, 2024 | 365,047.00 |
| Mar 31, 2024 | 372,363.00 |
| Dec 31, 2023 | 379,680.00 |
| Sep 30, 2023 | 386,997.00 |
| Jun 30, 2023 | 394,313.00 |
| Mar 31, 2023 | 401,630.00 |
| Dec 31, 2022 | 408,947.00 |
| Sep 30, 2022 | 416,263.00 |
| Jun 30, 2022 | 423,580.00 |
| Mar 31, 2022 | 430,897.00 |
| Dec 31, 2021 | 439,000.00 |